Wegovy and other semaglutide formulations have gained attention for weight loss, but emerging evidence points to a secondary benefit: potential reductions in systemic inflammation
For this purpose, sixty-four dogs were randomly assigned to different diet groups: a control diet, a diet with 7% MCTs, a diet containing FO (comprising 0.18% eicosapentaenoate and 1.3% docosahexaenoate), or a diet combining FO and MCTs
It is primarily indicated for adults and adolescents who are overweight or obese or who have a weight-related medical condition
Human trial BPC-157 was formally evaluated "in trials for inflammatory bowel disease" (PL-10, PLD-116, PL-14736
Inhibition of ACSL4 prevented radiation-induced ferroptosis in intestinal epithelial cells [31]
Healthcare providers are increasingly focusing on monitoring body composition changes rather than just weight loss numbers, as maintaining muscle mass is crucial for long-term health outcomes